Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03708003
Brief Title: Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL

First Submitted : October 12, 2018
First Submitted that Met QC Criteria : October 12, 2018
First Posted : October 16, 2018

Last Update Submitted that Met QC Criteria : February 25, 2020
Last Update Posted : February 26, 2020 (Estimate)